Literature DB >> 30225503

Icariin and icaritin recover UVB-induced photoaging by stimulating Nrf2/ARE and reducing AP-1 and NF-κB signaling pathways: a comparative study on UVB-irradiated human keratinocytes.

Eunson Hwang1, Pei Lin, Hien T T Ngo, Wei Gao, Yu-Shuai Wang, Hong-Shan Yu, Tae-Hoo Yi.   

Abstract

Icariin (ICA) and icaritin (ICT) exhibit many pharmacological functions including anti-osteoporosis, anti-cardiovascular, and anti-cancer activities; however, there are few comprehensive studies that track the detailed effects on UVB-induced photoaging. The recovery effects of ICA and ICT were investigated in UVB-irradiated human keratinocytes (HaCaTs). The results indicated that ICT and ICA showed strong radical scavenging activity, and the reactive oxygen species (ROS) scavenging activity of ICT was superior. UVB-induced matrix metalloproteinase-1 (MMP-1) expression was blocked by ICA via the inhibition of mitogen-activated protein kinase/activator protein 1 (MAPK/AP-1), which directly reduced extracellular matrix (ECM) degradation. ICT activated nuclear factor erythroid 2 related factor 2 (Nrf2) to improve the anti-oxidative stress capacity and suppress nuclear factor-κB (NF-κB) activation, decreasing vascular endothelial growth factor (VEGF) protein, and inflammatory cytokines induced ECM degrading enzyme secretion. Moreover, ICT was more advantageous to improve transforming growth factor beta 1 (TGF-β1) and procollagen type I expression than ICA, promoting the synthesis of collagen. Therefore, ICA and ICT have potential to treat UVB-induced oxidative stress, inflammation and photoaging, and will be posited as a novel strategy to alleviate photodamage.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30225503     DOI: 10.1039/c8pp00174j

Source DB:  PubMed          Journal:  Photochem Photobiol Sci        ISSN: 1474-905X            Impact factor:   3.982


  7 in total

1.  Solamargine Alleviated UVB-Induced Inflammation and Melanogenesis in Human Keratinocytes and Melanocytes via the p38 MAPK Signaling Pathway, a Promising Agent for Post-inflammatory Hyperpigmentation.

Authors:  Juemin Zhao; Yanjun Dan; Ziqi Liu; Qianqian Wang; Min Jiang; Chengfeng Zhang; Hamm-Ming Sheu; Chrang-Shi Lin; Leihong Xiang
Journal:  Front Med (Lausanne)       Date:  2022-06-13

Review 2.  Antiosteoporosis Effects, Pharmacokinetics, and Drug Delivery Systems of Icaritin: Advances and Prospects.

Authors:  Lifang Gao; Shuang-Qing Zhang
Journal:  Pharmaceuticals (Basel)       Date:  2022-03-24

Review 3.  Dietary Supplements and Natural Products: An Update on Their Clinical Effectiveness and Molecular Mechanisms of Action During Accelerated Biological Aging.

Authors:  Ye Chen; Sherif Hamidu; Xintong Yang; Yiqi Yan; Qilong Wang; Lin Li; Patrick Kwabena Oduro; Yuhong Li
Journal:  Front Genet       Date:  2022-04-28       Impact factor: 4.772

4.  Icariin Mitigates the Growth and Invasion Ability of Human Oral Squamous Cell Carcinoma via Inhibiting Toll-Like Receptor 4 and Phosphorylation of NF-κB P65.

Authors:  Ke Lei; Bing Ma; Ping Shi; Che Jin; Tan Ling; Longjiang Li; Xiangyi He; Lunchang Wang
Journal:  Onco Targets Ther       Date:  2020-01-10       Impact factor: 4.147

5.  The neuroprotective effects of icariin on ageing, various neurological, neuropsychiatric disorders, and brain injury induced by radiation exposure.

Authors:  Ling Rui Li; Gautam Sethi; Xing Zhang; Cui Liu Liu; Yan Huang; Qun Liu; Bo Xu Ren; Feng Ru Tang
Journal:  Aging (Albany NY)       Date:  2022-02-14       Impact factor: 5.682

6.  Chemical Distance Measurement and System Pharmacology Approach Uncover the Novel Protective Effects of Biotransformed Ginsenoside C-Mc against UVB-Irradiated Photoaging.

Authors:  Xiao-Yi Liu; Hui Li; Eunson Hwang; Bom Park; Yong-Kun Xiao; Senmiao Liu; Jiansong Fang; Yeon-Ju Kim; Tae-Hoo Yi; Chuipu Cai
Journal:  Oxid Med Cell Longev       Date:  2022-02-09       Impact factor: 6.543

7.  Icaritin Inhibits Migration and Invasion of Human Ovarian Cancer Cells via the Akt/mTOR Signaling Pathway.

Authors:  Lvfen Gao; Yuan Ouyang; Ruobin Li; Xian Zhang; Xuesong Gao; Shaoqiang Lin; Xiaoyu Wang
Journal:  Front Oncol       Date:  2022-04-01       Impact factor: 5.738

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.